SUSAN E. KNIGHT - 09 Feb 2023 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John Manders, on behalf of Susan E. Knight
Issuer symbol
SRDX
Transactions as of
09 Feb 2023
Net transactions value
$0
Form type
4
Filing time
13 Feb 2023, 15:20:32 UTC
Previous filing
02 Mar 2022
Next filing
07 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Award $0 +2,139 +7.1% $0.000000 32,335 09 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Award $0 +5,040 $0.000000 5,040 09 Feb 2023 Common Stock 5,040 $28.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 15,342 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 The stock options vest ratably on a monthly basis and become fully vested on February 9, 2024, the 12-month anniversary of the grant date.